Hologic Inc at Goldman Sachs Credit and Leveraged Finance Conference Transcript
Okay. Great. Let's go ahead and start our next presentation. So I am Frank Jarman, again, our high-yield technology analyst -- or sorry, high yield health care analyst here at Goldman Sachs. And I am very pleased to have Hologic here with us today. From Hologic, we have Michael Watts, who's Vice President of Investor Relations and Corporate Development; and Marci Lerner, who is Vice President and Treasurer of the company. So Michael and Marci, thank you both so much for joining us today. The Hologic team is going to start off with a couple of slides, and then we'll wrap up with some Q&A.
And with that, Michael, I will go ahead and pass the floor over to you.
Yes. Thank you, Frank, and thanks to Goldman for having us. We're glad to be here.
Let me just reference Slide 2 to begin. That's our safe harbor statement. Obviously, we will be making some forward-looking statements this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |